FG
Forbion Growth Opportunities Fund III Cooperatief U.A. disclosed a 8.4% stake in MPLT
Forbion Growth Opportunities Fund III Cooperatief U.A. reported owning 8.4% of MapLight Therapeutics, Inc. (MPLT) (4,428,328 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G